FilingSEC EDGAR8-K
GT Biopharma Implements 1-for-25 Reverse Stock Split and Reduces Authorized Shares
· SEC accepted
Stagecompleted
Filing content
GT Biopharma announced a 1-for-25 reverse stock split effective September 8, 2026, and a reduction of authorized common shares to 25,000,000.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…